Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03561272 · ClinicalTrials.gov registry record · NA
The Validation of a Novel Adherence Method for Oral Oncolytics
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03561272 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 18 participants.
The verdict
NCT03561272, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The long-term goal of this research is to apply technologic approaches to improve the use of oral oncolytics. The objective of this study is to assess patient adherence to oral oncolytics and to validate a currently available smart phone application (iRxReminder) partnered with an automated dispensing device, a "Pod", in affecting patient adherence. The rationale for this study is that medication adherence to oncolytics varies and strategies are needed to improve it.
Interventions
- OTHER Smart Phone Application
- OTHER POD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2018-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03561272
The ClinicalTrials.gov registry entry for NCT03561272 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smart Phone Application is the first listed.
NCT03561272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03561272 about?
NCT03561272 is a clinical study titled "The Validation of a Novel Adherence Method for Oral Oncolytics". The long-term goal of this research is to apply technologic approaches to improve the use of oral oncolytics. The objective of this study is to assess patient adherence to oral oncolytics and to validate a currently available smart phone application (iRxReminder) partnered with an automated dispensi...
What is the current status of trial NCT03561272?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-06-20. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03561272?
The interventions under investigation include: Smart Phone Application (OTHER), POD (OTHER).
Who is sponsoring clinical trial NCT03561272?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.